Dostarlimab [2022215-59-2]

TargetMol Chemicals

Dostarlimab

9

2022215-59-2

Antibody

Research Use Only

Dostarlimab

Dostarlimab (TSR-042) is a high-affinity, humanized monoclonal antibody targeting PD-1, designed to block its interaction with ligands PD-L1 and PD-L2, achieving IC50 values of 1.8 nM for PD-L1 and 1.5 nM for PD-L2, thus demonstrating effective inhibition capabilities [1].

3 years

-20°C

12352203